Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise
The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated fr...
Saved in:
Published in | Hypertension research Vol. 35; no. 1; pp. 41 - 47 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.01.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 0916-9636 1348-4214 1348-4214 |
DOI | 10.1038/hr.2011.134 |
Cover
Abstract | The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated from measures of plasma norepinephrine (NE), and insulin resistance (homeostasis model of insulin resistance, HOMA-IR). The three groups each comprised 30 obese, hypertensive men. Body mass index (BMI), fat mass, waist-to-hip ratio, BP, plasma NE and HOMA-IR were measured every 2 weeks during the first 4 weeks and subsequently every 4 weeks for the next 20 weeks. All basal parameters were similar among the three groups. At 24 weeks, the combination group with D+EX comprised a significantly higher prevalence of normotensive subjects than the D alone or EX alone group (
P
<0.05). In the D alone group, plasma NE was decreased significantly at 2 weeks, reductions in BMI, fat mass and BP were observed at 8 weeks, and waist-to-hip ratios and HOMA-IR were decreased at 12 weeks. In comparison, in the EX alone group, significant reductions of fat mass and HOMA-IR were observed at 4 weeks. Plasma NE and HOMA-IR were reduced at 8 weeks while decreases in BP were detected at 12 weeks. In the D+EX group, significant reductions in plasma NE were observed at 2 weeks followed by significant decreases in BMI, fat mass, waist-to-hip ratio, BP levels and HOMA-IR at 4 weeks. The magnitudes of reductions of all parameters were greatest in the D+EX group. These results demonstrate that D+EX exerts a stronger ameliorative effect on weight loss, weight loss-induced BP reduction, normalization of BP, sympathetic activation and insulin resistance compared with D or EX alone. D and EX might, perhaps, exert different mechanisms on weight loss and weight loss-induced BP reduction; however, a combination of caloric restriction and exercise is preferred to control BP levels in obese hypertensive patients. |
---|---|
AbstractList | The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated from measures of plasma norepinephrine (NE), and insulin resistance (homeostasis model of insulin resistance, HOMA-IR). The three groups each comprised 30 obese, hypertensive men. Body mass index (BMI), fat mass, waist-to-hip ratio, BP, plasma NE and HOMA-IR were measured every 2 weeks during the first 4 weeks and subsequently every 4 weeks for the next 20 weeks. All basal parameters were similar among the three groups. At 24 weeks, the combination group with D+EX comprised a significantly higher prevalence of normotensive subjects than the D alone or EX alone group (P<0.05). In the D alone group, plasma NE was decreased significantly at 2 weeks, reductions in BMI, fat mass and BP were observed at 8 weeks, and waist-to-hip ratios and HOMA-IR were decreased at 12 weeks. In comparison, in the EX alone group, significant reductions of fat mass and HOMA-IR were observed at 4 weeks. Plasma NE and HOMA-IR were reduced at 8 weeks while decreases in BP were detected at 12 weeks. In the D+EX group, significant reductions in plasma NE were observed at 2 weeks followed by significant decreases in BMI, fat mass, waist-to-hip ratio, BP levels and HOMA-IR at 4 weeks. The magnitudes of reductions of all parameters were greatest in the D+EX group. These results demonstrate that D+EX exerts a stronger ameliorative effect on weight loss, weight loss-induced BP reduction, normalization of BP, sympathetic activation and insulin resistance compared with D or EX alone. D and EX might, perhaps, exert different mechanisms on weight loss and weight loss-induced BP reduction; however, a combination of caloric restriction and exercise is preferred to control BP levels in obese hypertensive patients.The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated from measures of plasma norepinephrine (NE), and insulin resistance (homeostasis model of insulin resistance, HOMA-IR). The three groups each comprised 30 obese, hypertensive men. Body mass index (BMI), fat mass, waist-to-hip ratio, BP, plasma NE and HOMA-IR were measured every 2 weeks during the first 4 weeks and subsequently every 4 weeks for the next 20 weeks. All basal parameters were similar among the three groups. At 24 weeks, the combination group with D+EX comprised a significantly higher prevalence of normotensive subjects than the D alone or EX alone group (P<0.05). In the D alone group, plasma NE was decreased significantly at 2 weeks, reductions in BMI, fat mass and BP were observed at 8 weeks, and waist-to-hip ratios and HOMA-IR were decreased at 12 weeks. In comparison, in the EX alone group, significant reductions of fat mass and HOMA-IR were observed at 4 weeks. Plasma NE and HOMA-IR were reduced at 8 weeks while decreases in BP were detected at 12 weeks. In the D+EX group, significant reductions in plasma NE were observed at 2 weeks followed by significant decreases in BMI, fat mass, waist-to-hip ratio, BP levels and HOMA-IR at 4 weeks. The magnitudes of reductions of all parameters were greatest in the D+EX group. These results demonstrate that D+EX exerts a stronger ameliorative effect on weight loss, weight loss-induced BP reduction, normalization of BP, sympathetic activation and insulin resistance compared with D or EX alone. D and EX might, perhaps, exert different mechanisms on weight loss and weight loss-induced BP reduction; however, a combination of caloric restriction and exercise is preferred to control BP levels in obese hypertensive patients. The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated from measures of plasma norepinephrine (NE), and insulin resistance (homeostasis model of insulin resistance, HOMA-IR). The three groups each comprised 30 obese, hypertensive men. Body mass index (BMI), fat mass, waist-to-hip ratio, BP, plasma NE and HOMA-IR were measured every 2 weeks during the first 4 weeks and subsequently every 4 weeks for the next 20 weeks. All basal parameters were similar among the three groups. At 24 weeks, the combination group with D+EX comprised a significantly higher prevalence of normotensive subjects than the D alone or EX alone group ( P <0.05). In the D alone group, plasma NE was decreased significantly at 2 weeks, reductions in BMI, fat mass and BP were observed at 8 weeks, and waist-to-hip ratios and HOMA-IR were decreased at 12 weeks. In comparison, in the EX alone group, significant reductions of fat mass and HOMA-IR were observed at 4 weeks. Plasma NE and HOMA-IR were reduced at 8 weeks while decreases in BP were detected at 12 weeks. In the D+EX group, significant reductions in plasma NE were observed at 2 weeks followed by significant decreases in BMI, fat mass, waist-to-hip ratio, BP levels and HOMA-IR at 4 weeks. The magnitudes of reductions of all parameters were greatest in the D+EX group. These results demonstrate that D+EX exerts a stronger ameliorative effect on weight loss, weight loss-induced BP reduction, normalization of BP, sympathetic activation and insulin resistance compared with D or EX alone. D and EX might, perhaps, exert different mechanisms on weight loss and weight loss-induced BP reduction; however, a combination of caloric restriction and exercise is preferred to control BP levels in obese hypertensive patients. The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated from measures of plasma norepinephrine (NE), and insulin resistance (homeostasis model of insulin resistance, HOMA-IR). The three groups each comprised 30 obese, hypertensive men. Body mass index (BMI), fat mass, waist-to-hip ratio, BP, plasma NE and HOMA-IR were measured every 2 weeks during the first 4 weeks and subsequently every 4 weeks for the next 20 weeks. All basal parameters were similar among the three groups. At 24 weeks, the combination group with D+EX comprised a significantly higher prevalence of normotensive subjects than the D alone or EX alone group (P<0.05). In the D alone group, plasma NE was decreased significantly at 2 weeks, reductions in BMI, fat mass and BP were observed at 8 weeks, and waist-to-hip ratios and HOMA-IR were decreased at 12 weeks. In comparison, in the EX alone group, significant reductions of fat mass and HOMA-IR were observed at 4 weeks. Plasma NE and HOMA-IR were reduced at 8 weeks while decreases in BP were detected at 12 weeks. In the D+EX group, significant reductions in plasma NE were observed at 2 weeks followed by significant decreases in BMI, fat mass, waist-to-hip ratio, BP levels and HOMA-IR at 4 weeks. The magnitudes of reductions of all parameters were greatest in the D+EX group. These results demonstrate that D+EX exerts a stronger ameliorative effect on weight loss, weight loss-induced BP reduction, normalization of BP, sympathetic activation and insulin resistance compared with D or EX alone. D and EX might, perhaps, exert different mechanisms on weight loss and weight loss-induced BP reduction; however, a combination of caloric restriction and exercise is preferred to control BP levels in obese hypertensive patients. |
Author | MASUO Kazuko OGIHARA Toshio W LAMBERT Gavin RAKUGI Hiromi |
Author_xml | – sequence: 1 givenname: Kazuko surname: Masuo fullname: Masuo, Kazuko email: kazuko.masuo@bakeridi.edu.au organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Nucleus Network Ltd, Baker IDI Heart & Diabetes Institute – sequence: 2 givenname: Hiromi surname: Rakugi fullname: Rakugi, Hiromi organization: Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine – sequence: 3 givenname: Toshio surname: Ogihara fullname: Ogihara, Toshio organization: Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine – sequence: 4 givenname: Gavin W surname: Lambert fullname: Lambert, Gavin W organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University |
BackLink | https://cir.nii.ac.jp/crid/1570009750864846464$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/21814218$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1rHSEUhqUkNDdpV90XF4Uu2rn1axxdhvQrEMimXYujZ3INM3qrDmn_fbzctItCEI4gz_sizzlHJzFFQOgNJVtKuPq0y1tGKN1SLl6gTZuqE4yKE7QhmspOSy7P0Hkp94Qw1Wv6Ep0xqmhj1AaVz2GaIEOseAG3szGUpeAQ8QOEu13FcyqlC9GvDjwe55Q83mcoZc2AM7TnGlLEI9QHgIgtdnZOOUDXmJqDqy3lA1Rso8fwG7ILBV6h08nOBV4_3Rfo59cvP66-dze3366vLm86JxStnR4EFR44I8xPnnMmxKCnXloYrZ48eMo5EBBstIKwkTvSD1yN2nHoh36c-AV6f-zd5_RrbR8ySygO5tlGSGsxmgopOZdDI98-keu4gDf7HBab_5i_nhrw4Qi43IRkmP4hlJjDFswum8MWTPPfaPof7UK1B1M12zA_k_l4zJTWHO8gm_u05tj8PIO_O-IxhNZ-mLQfCCF66ImSQgnZDn8E9O6kSw |
CitedBy_id | crossref_primary_10_1038_hr_2013_152 crossref_primary_10_1002_14651858_CD008274_pub4 crossref_primary_10_1016_j_smrv_2016_12_001 crossref_primary_10_1002_14651858_CD008274_pub3 crossref_primary_10_1159_000531798 crossref_primary_10_3390_foods13071079 crossref_primary_10_1152_ajpheart_00096_2015 crossref_primary_10_1038_hr_2016_142 crossref_primary_10_1016_j_ypmed_2018_07_007 crossref_primary_10_1152_japplphysiol_00362_2016 crossref_primary_10_1177_2047487319871233 crossref_primary_10_1111_obr_13269 crossref_primary_10_1093_pubmed_fdw077 crossref_primary_10_1016_j_metabol_2012_09_005 crossref_primary_10_3390_molecules26113168 crossref_primary_10_1080_10408398_2022_2064424 crossref_primary_10_1093_ajh_hpu050 crossref_primary_10_1292_jvms_13_0475 crossref_primary_10_1097_GME_0b013e3182831ee4 crossref_primary_10_7570_jomes_2019_28_4_278 crossref_primary_10_1007_s11906_014_0426_z crossref_primary_10_1111_jch_12853 |
Cites_doi | 10.1016/S0828-282X(10)70379-2 10.1111/j.1467-789X.2007.00393.x 10.1097/HJH.0b013e3283418875 10.1007/s11906-010-0168-5 10.1186/1471-2458-10-766 10.7326/0003-4819-142-8-200504190-00009 10.3945/ajcn.2008.26299 10.1097/00004872-200103001-00001 10.1093/ajh/7.5.402 10.1161/01.HYP.25.4.560 10.1161/01.HYP.0000037217.96002.8E 10.1590/S0100-879X2006000100006 10.1097/00005344-200000004-00001 10.1001/jama.2010.1505 10.2337/db08-1595 10.1016/S0895-7061(00)01279-6 10.1056/NEJMoa066603 10.1161/01.CIR.0000161959.04675.5A 10.7326/0003-4819-136-7-200204020-00006 10.1161/01.HYP.5.5.767 10.1161/01.HYP.4.5.686 10.1161/01.HYP.35.5.1135 10.5694/j.1326-5377.2009.tb02753.x 10.1001/jama.282.16.1519 10.1097/00004872-199816121-00019 10.1007/s11906-010-0135-1 10.1111/j.1600-0838.2006.00631.x 10.1161/HYPERTENSIONAHA.109.149153 10.1210/jc.2005-0961 10.1186/1471-2261-8-12 10.1152/ajpheart.01090.2002 10.1001/archinte.1984.00350200073012 10.2337/diacare.26.8.2426 10.1001/archinternmed.2009.470 10.1093/ajh/2.3.140S 10.1161/01.HYP.18.5.575 10.1053/j.jrn.2007.10.024 10.2174/157340210791171038 10.1291/hypres.24.371 10.1006/pmed.1999.0602 10.4061/2010/832821 10.1016/j.amjhyper.2004.09.011 10.1161/CIRCULATIONAHA.104.519652 10.1291/hypres.30.503 10.1046/j.1365-2796.2000.00568.x 10.1097/HJH.0b013e328302f10d 10.1161/hc1102.105261 10.1161/HYPERTENSIONAHA.109.146795 10.2337/db09-0934 10.1001/jama.289.1.76 10.1038/hr.2008.2 10.1161/HYPERTENSIONAHA.107.094649 10.1152/ajpendo.00469.2010 |
ContentType | Journal Article |
Copyright | The Japanese Society of Hypertension 2012 |
Copyright_xml | – notice: The Japanese Society of Hypertension 2012 |
DBID | RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1038/hr.2011.134 |
DatabaseName | CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1348-4214 |
EndPage | 47 |
ExternalDocumentID | 21814218 10_1038_hr_2011_134 10030642760 |
Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -Q- 0R~ 29I 39C 4.4 406 53G 5GY 70F 7X7 AANZL AASML ABAKF ABAWZ ABBRH ABDBE ABFSG ABJNI ABLJU ABZZP ACAOD ACGFO ACGFS ACKTT ACMFV ACMJI ACRQY ACSTC ACZOJ ADBBV AEFQL AEJRE AEMSY AENEX AESKC AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ATHPR AXYYD AYFIA BKKNO CS3 DNIVK DPUIP DU5 E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN F5P FDQFY FERAY FIZPM FSGXE FYUFA GX1 HZ~ IWAJR JSH JSO JZLTJ NQJWS O9- OK1 P2P RNT RNTTT ROL RYH SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TSG XSB .55 2WC 88E 8FI 8FJ AACDK AATNV ABRTQ ABUWG AFKRA BAWUL BENPR BPHCQ BVXVI CCPQU DIK FIGPU HMCUK JSF KQ8 LGEZI LOTEE M1P NADUK NXXTH PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO RJT RZJ TKC TR2 UKHRP W2D X7M AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c481t-97414de3202dfd3324479f56aeba9fded133e0e42ba402b3c05738b9c3e575bf3 |
ISSN | 0916-9636 1348-4214 |
IngestDate | Fri Sep 05 13:59:03 EDT 2025 Mon Jul 21 06:05:06 EDT 2025 Thu Apr 24 23:09:21 EDT 2025 Tue Jul 01 04:12:20 EDT 2025 Mon Jul 21 06:08:40 EDT 2025 Thu Jun 26 23:41:52 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | insulin resistance obesity a calorie-restricted diet an aerobic exercise sympathetic nervous activity |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c481t-97414de3202dfd3324479f56aeba9fded133e0e42ba402b3c05738b9c3e575bf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0001-6508-4338 |
OpenAccessLink | https://www.nature.com/articles/hr2011134.pdf |
PMID | 21814218 |
PQID | 914663367 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_914663367 pubmed_primary_21814218 crossref_primary_10_1038_hr_2011_134 crossref_citationtrail_10_1038_hr_2011_134 springer_journals_10_1038_hr_2011_134 nii_cinii_1570009750864846464 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-01-01 |
PublicationDateYYYYMMDD | 2012-01-01 |
PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Hypertension research |
PublicationTitleAbbrev | Hypertens Res |
PublicationTitleAlternate | Hypertens Res |
PublicationYear | 2012 |
Publisher | Nature Publishing Group UK |
Publisher_xml | – name: Nature Publishing Group UK |
References | JB Dixon (BFhr2011134_CR35) 2008; 299 MH Maxwell (BFhr2011134_CR44) 1994; 7 NE Straznicky (BFhr2011134_CR37) 2011; 29 NE Straznicky (BFhr2011134_CR56) 2009; 58 K Masuo (BFhr2011134_CR5) 2010; 2010 JSH 2009 (BFhr2011134_CR12) 2009; 32 BH Goodpaster (BFhr2011134_CR14) 2010; 304 WI Sivitz (BFhr2011134_CR48) 1999; 277 K Masuo (BFhr2011134_CR20) 2001; 14 TD Adams (BFhr2011134_CR34) 2007; 357 IT Meredith (BFhr2011134_CR49) 1991; 18 IM Claesson (BFhr2011134_CR21) 2010; 10 BFhr2011134_CR11 AH Mokdad (BFhr2011134_CR26) 1999; 282 LS Pescatello (BFhr2011134_CR55) 2008; 8 L Landsberg (BFhr2011134_CR3) 2001; 15 K Masuo (BFhr2011134_CR50) 1983; 5 K Masuo (BFhr2011134_CR40) 2005; 18 AH Mokdad (BFhr2011134_CR28) 2003; 289 NE Strazanicky (BFhr2011134_CR54) 2011; 29 K Masuo (BFhr2011134_CR4) 2005; 111 M Esler (BFhr2011134_CR6) 2000; 35 PJ Smith (BFhr2011134_CR18) 2010; 55 ER Miller III (BFhr2011134_CR15) 2002; 40 JR Sowers (BFhr2011134_CR43) 1982; 4 NE Straznicky (BFhr2011134_CR52) 2010; 50 M Esler (BFhr2011134_CR38) 1989; 2 SA Anderssen (BFhr2011134_CR32) 2007; 17 G Berglund (BFhr2011134_CR10) 2000; 247 MM Ribeiro (BFhr2011134_CR57) 2005; 111 G Grassi (BFhr2011134_CR1) 1995; 25 AS Poobalan (BFhr2011134_CR33) 2007; 8 JA Blumenthal (BFhr2011134_CR17) 2010; 55 TJ Orchard (BFhr2011134_CR31) 2005; 142 AL Himderliter (BFhr2011134_CR19) 2011; 13 IC Trombetta (BFhr2011134_CR58) 2003; 11 SP Whelton (BFhr2011134_CR16) 2002; 136 JA Blumenthal (BFhr2011134_CR53) 2010; 170 E Lambert (BFhr2011134_CR36) 2007; 50 L Gohler (BFhr2011134_CR46) 2000; 30 G Grassi (BFhr2011134_CR2) 1998; 16 GW Lambert (BFhr2011134_CR24) 2011; 6 NE Straznicky (BFhr2011134_CR47) 2005; 90 DG Hackam (BFhr2011134_CR13) 2010; 26 AC Tonacio (BFhr2011134_CR59) 2006; 39 GA Adesseun (BFhr2011134_CR22) 2010; 12 K Masuo (BFhr2011134_CR42) 2001; 24 K Masuo (BFhr2011134_CR7) 2007; 30 N Straznicky (BFhr2011134_CR41) 2009; 89 K Masuo (BFhr2011134_CR23) 2000; 35 DS Lee (BFhr2011134_CR27) 2009; 191 H Yokoyama (BFhr2011134_CR25) 2003; 26 C Zoccali (BFhr2011134_CR9) 2002; 105 MH Maxwell (BFhr2011134_CR51) 1984; 144 K Masuo (BFhr2011134_CR45) 2000; 36 G Mancia (BFhr2011134_CR29) 2008; 26 AJ Cameron (BFhr2011134_CR30) 2009; 191 AR Gosmanov (BFhr2011134_CR39) 2010; 299 A Ksiazek (BFhr2011134_CR8) 2008; 18 |
References_xml | – ident: BFhr2011134_CR11 – volume: 26 start-page: 249 year: 2010 ident: BFhr2011134_CR13 publication-title: Can J Cardiol doi: 10.1016/S0828-282X(10)70379-2 – volume: 8 start-page: 503 year: 2007 ident: BFhr2011134_CR33 publication-title: Obes Rev doi: 10.1111/j.1467-789X.2007.00393.x – volume: 29 start-page: 553 year: 2011 ident: BFhr2011134_CR54 publication-title: J Hypertens doi: 10.1097/HJH.0b013e3283418875 – volume: 13 start-page: 67 year: 2011 ident: BFhr2011134_CR19 publication-title: Curr Hypertens Rep doi: 10.1007/s11906-010-0168-5 – volume: 10 start-page: 766 year: 2010 ident: BFhr2011134_CR21 publication-title: BMC Public Health doi: 10.1186/1471-2458-10-766 – volume: 142 start-page: 611 year: 2005 ident: BFhr2011134_CR31 publication-title: Am Intern Med doi: 10.7326/0003-4819-142-8-200504190-00009 – volume: 89 start-page: 27 year: 2009 ident: BFhr2011134_CR41 publication-title: Am J Clin Nutr doi: 10.3945/ajcn.2008.26299 – volume: 15 start-page: 523 year: 2001 ident: BFhr2011134_CR3 publication-title: J Hypertens doi: 10.1097/00004872-200103001-00001 – volume: 7 start-page: 402 year: 1994 ident: BFhr2011134_CR44 publication-title: Am J Hypertens doi: 10.1093/ajh/7.5.402 – volume: 25 start-page: 560 issue: Pt 1 year: 1995 ident: BFhr2011134_CR1 publication-title: Hypertension doi: 10.1161/01.HYP.25.4.560 – volume: 40 start-page: 612 year: 2002 ident: BFhr2011134_CR15 publication-title: Hypertension doi: 10.1161/01.HYP.0000037217.96002.8E – volume: 39 start-page: 53 year: 2006 ident: BFhr2011134_CR59 publication-title: Braz J Med Biol Res doi: 10.1590/S0100-879X2006000100006 – volume: 35 start-page: S1 issue: Suppl 4 year: 2000 ident: BFhr2011134_CR6 publication-title: J Cardiovasc Pharmacol doi: 10.1097/00005344-200000004-00001 – volume: 304 start-page: 1795 year: 2010 ident: BFhr2011134_CR14 publication-title: JAMA doi: 10.1001/jama.2010.1505 – volume: 29 start-page: 553 year: 2011 ident: BFhr2011134_CR37 publication-title: J Hypertens doi: 10.1097/HJH.0b013e3283418875 – volume: 58 start-page: 1126 year: 2009 ident: BFhr2011134_CR56 publication-title: Diabetes doi: 10.2337/db08-1595 – volume: 14 start-page: 530 issue: Pt 1 year: 2001 ident: BFhr2011134_CR20 publication-title: Am J Hypertens doi: 10.1016/S0895-7061(00)01279-6 – volume: 357 start-page: 753 year: 2007 ident: BFhr2011134_CR34 publication-title: N Engl J Med doi: 10.1056/NEJMoa066603 – volume: 111 start-page: 1915 year: 2005 ident: BFhr2011134_CR57 publication-title: Circulation doi: 10.1161/01.CIR.0000161959.04675.5A – volume: 136 start-page: 493 year: 2002 ident: BFhr2011134_CR16 publication-title: An Intern Med doi: 10.7326/0003-4819-136-7-200204020-00006 – volume: 5 start-page: 767 year: 1983 ident: BFhr2011134_CR50 publication-title: Hypertension doi: 10.1161/01.HYP.5.5.767 – volume: 4 start-page: 686 year: 1982 ident: BFhr2011134_CR43 publication-title: Hypertension doi: 10.1161/01.HYP.4.5.686 – volume: 299 start-page: 316 year: 2008 ident: BFhr2011134_CR35 publication-title: JAMA – volume: 35 start-page: 1135 year: 2000 ident: BFhr2011134_CR23 publication-title: Hypertension doi: 10.1161/01.HYP.35.5.1135 – volume: 191 start-page: 202 year: 2009 ident: BFhr2011134_CR30 publication-title: Med J Aust doi: 10.5694/j.1326-5377.2009.tb02753.x – volume: 282 start-page: 1519 year: 1999 ident: BFhr2011134_CR26 publication-title: JAMA doi: 10.1001/jama.282.16.1519 – volume: 16 start-page: 1979 issue: Pt 2 year: 1998 ident: BFhr2011134_CR2 publication-title: J Hypertens doi: 10.1097/00004872-199816121-00019 – volume: 12 start-page: 378 year: 2010 ident: BFhr2011134_CR22 publication-title: Curr Hypertens Rep doi: 10.1007/s11906-010-0135-1 – volume: 17 start-page: 687 year: 2007 ident: BFhr2011134_CR32 publication-title: Scand J Med Sci Sports doi: 10.1111/j.1600-0838.2006.00631.x – volume: 55 start-page: 1199 year: 2010 ident: BFhr2011134_CR17 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.109.149153 – volume: 90 start-page: 5998 year: 2005 ident: BFhr2011134_CR47 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-0961 – volume: 8 start-page: 12 year: 2008 ident: BFhr2011134_CR55 publication-title: BMC Cardiovascular Disorders doi: 10.1186/1471-2261-8-12 – volume: 11 start-page: H974 year: 2003 ident: BFhr2011134_CR58 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.01090.2002 – volume: 144 start-page: 1581 year: 1984 ident: BFhr2011134_CR51 publication-title: Arch Intern Med doi: 10.1001/archinte.1984.00350200073012 – volume: 26 start-page: 2426 year: 2003 ident: BFhr2011134_CR25 publication-title: Diabetes Care doi: 10.2337/diacare.26.8.2426 – volume: 170 start-page: 126 year: 2010 ident: BFhr2011134_CR53 publication-title: Arch Intern Med doi: 10.1001/archinternmed.2009.470 – volume: 277 start-page: E668 issue: Pt 1 year: 1999 ident: BFhr2011134_CR48 publication-title: Am J Physiol – volume: 2 start-page: S140 year: 1989 ident: BFhr2011134_CR38 publication-title: Am J Hypertens doi: 10.1093/ajh/2.3.140S – volume: 18 start-page: 575 year: 1991 ident: BFhr2011134_CR49 publication-title: Hypertension doi: 10.1161/01.HYP.18.5.575 – volume: 18 start-page: 118 year: 2008 ident: BFhr2011134_CR8 publication-title: J Ren Nutr doi: 10.1053/j.jrn.2007.10.024 – volume: 6 start-page: 130 year: 2011 ident: BFhr2011134_CR24 publication-title: Curr Hypertens Rev doi: 10.2174/157340210791171038 – volume: 24 start-page: 371 year: 2001 ident: BFhr2011134_CR42 publication-title: Hypertens Res doi: 10.1291/hypres.24.371 – volume: 30 start-page: 95 year: 2000 ident: BFhr2011134_CR46 publication-title: Prev Med doi: 10.1006/pmed.1999.0602 – volume: 2010 start-page: 832821 year: 2010 ident: BFhr2011134_CR5 publication-title: Int J Hypertens doi: 10.4061/2010/832821 – volume: 191 start-page: E55 year: 2009 ident: BFhr2011134_CR27 publication-title: CMAJ – volume: 36 start-page: 17 issue: Suppl 2 year: 2000 ident: BFhr2011134_CR45 publication-title: Hypertension – volume: 18 start-page: 235 issue: 2 Pt 1 year: 2005 ident: BFhr2011134_CR40 publication-title: Am J Hypertens doi: 10.1016/j.amjhyper.2004.09.011 – volume: 111 start-page: 3429 year: 2005 ident: BFhr2011134_CR4 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.104.519652 – volume: 30 start-page: 503 year: 2007 ident: BFhr2011134_CR7 publication-title: Hypertens Res doi: 10.1291/hypres.30.503 – volume: 247 start-page: 19 year: 2000 ident: BFhr2011134_CR10 publication-title: J Intern Med doi: 10.1046/j.1365-2796.2000.00568.x – volume: 26 start-page: 1602 year: 2008 ident: BFhr2011134_CR29 publication-title: J Hypertens doi: 10.1097/HJH.0b013e328302f10d – volume: 105 start-page: 1354 year: 2002 ident: BFhr2011134_CR9 publication-title: Circulation doi: 10.1161/hc1102.105261 – volume: 55 start-page: 1331 year: 2010 ident: BFhr2011134_CR18 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.109.146795 – volume: 50 start-page: 71 year: 2010 ident: BFhr2011134_CR52 publication-title: Diabetes doi: 10.2337/db09-0934 – volume: 289 start-page: 76 year: 2003 ident: BFhr2011134_CR28 publication-title: JAMA doi: 10.1001/jama.289.1.76 – volume: 32 start-page: 11 year: 2009 ident: BFhr2011134_CR12 publication-title: Hypertens Res doi: 10.1038/hr.2008.2 – volume: 50 start-page: 862 year: 2007 ident: BFhr2011134_CR36 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.107.094649 – volume: 299 start-page: E953 year: 2010 ident: BFhr2011134_CR39 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00469.2010 |
SSID | ssj0028591 |
Score | 2.1198494 |
Snippet | The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced... |
SourceID | proquest pubmed crossref springer nii |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 41 |
SubjectTerms | a calorie-restricted diet Adult an aerobic exercise Blood Pressure - physiology Body Mass Index Diet, Reducing Exercise - physiology Geriatrics/Gerontology Health Promotion and Disease Prevention Humans Hypertension - complications Hypertension - physiopathology insulin resistance Insulin Resistance - physiology Internal Medicine Male Medicine Medicine & Public Health Middle Aged Norepinephrine - blood obesity Obesity - complications Obesity - physiopathology Obstetrics/Perinatology/Midwifery original-article Public Health sympathetic nervous activity Waist-Hip Ratio Weight Loss - physiology |
Title | Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise |
URI | https://cir.nii.ac.jp/crid/1570009750864846464 https://link.springer.com/article/10.1038/hr.2011.134 https://www.ncbi.nlm.nih.gov/pubmed/21814218 https://www.proquest.com/docview/914663367 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb5tAEF41iVT1UvUd0qbaQ3qpRQrsYvAxaeNaleNebNU3BMsSo8RQgUml_PrO7C7Yli31IUvIQnjBfB_DvIeQM5kBK_wgtgMmfJu7Utghyxyc9SLhAeGBVO2arif90Yx_m_vzdQRfVZesknPxsLeu5H9QhX2AK1bJ_gOy3aKwA74DvrAFhGH7Vxh_MdNNVr2lxArevF6q9NZfyt_Zu4MXoA02d4MxfpWh3lNprxgzqLBlq8K-zdSKewBXCZazjeM6QDyiLprmUqegt6OZNpXZEdiwlcqAL7EoZsMvplzcdVPqfI2H5rZcx5Numxs9KTuvymXeOXlvcmwdrehT1ou8-8E4xpEl6lXxNb6HP_dj01GhMj5aR4WWrQx9l56uGT2Xe_YZgaz7l2wRT0tX3SJrR-jrFu-LSjdkdY1zdKu19uR7NJyNx9H0aj49IEdeEGBM_-hieHk56exzbOWn7HNzTaacE5b_tLH4lgJzUOT5PttkJ66u1JXpM_LU2Bn0QpPmOXkkixfk8bXJpHhJ6o47dM0dmhdUc4ducocq7tCWO7TjDjXcoTHd5Q5F7lDgDm2584rMhlfTzyPbDOCwBQ_dlQ22pstTyTzHS7OUge7Ng0Hm92OZxIMslanLmHQk95KYO17CBHbXDJOBYBKsgCRjr8lhURbymNAkEKnn-E7MBi6H-xyC6Beg_nuSg40aCIt8bO9qJEx3ehySchepLAkWRosqQggigMAiZ93BP3VTlv2HnQI8sBxuXRzk4AxAQQ77HJRu-FiEtsBFIFQxUhYXsmzqCK4RNHHWDyzyRgPanQdVYiBHaJEPLcKREQn1vos4-fNJ3pIn6-flHTlcVY08BVV3lbw3FP0NZ7iq_A |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Different+mechanisms+in+weight+loss-induced+blood+pressure+reduction+between+a+calorie-restricted+diet+and+exercise&rft.jtitle=Hypertension+research&rft.au=Masuo%2C+Kazuko&rft.au=Rakugi%2C+Hiromi&rft.au=Ogihara%2C+Toshio&rft.au=Lambert%2C+Gavin+W&rft.date=2012-01-01&rft.issn=1348-4214&rft.eissn=1348-4214&rft.volume=35&rft.issue=1&rft.spage=41&rft_id=info:doi/10.1038%2Fhr.2011.134&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-9636&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-9636&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-9636&client=summon |